Phillips Medisize Boosts Medical Inhaler Portfolio With Vectura Acquisition

Phillips Medisize Boosts Medical Inhaler Portfolio With Vectura Acquisition

Source: 
Medical Devices and Diagnostics Industry
snippet: 

Phillips Medisize, a contract development and manufacturing organization serving medical device and pharma OEMs acquired by Molex in 2016, announced today that it has completed the acquisition of Vectura Group Ltd. from Vectura Fertin Pharma Inc., a subsidiary of Philip Morris International Inc. The acquisition adds proprietary technology and combination product development expertise in medical inhalers to the Phillips Medisize portfolio.